Evaluation of CCNU (NSC 79037) used for the prevention of CNS involvement in burkitt's lymphoma
| dc.contributor.author | Ziegler, J.L. | |
| dc.contributor.author | Magrath, I.T. | |
| dc.contributor.author | Nkrumah, F.K. | |
| dc.contributor.author | Perkins, I.V. | |
| dc.contributor.author | Simon, R | |
| dc.date.accessioned | 2013-06-21T14:42:41Z | |
| dc.date.accessioned | 2017-10-16T13:15:25Z | |
| dc.date.available | 2013-06-21T14:42:41Z | |
| dc.date.available | 2017-10-16T13:15:25Z | |
| dc.date.issued | 1975 | |
| dc.identifier.citation | Ziegler, J. L., Magrath, I. T., Nkrumah, F. K., Perkins, I. V., & Simon, R. (1975). Evaluation of CCNU (NSC 79037) used for the prevention of CNS involvement in burkitt's lymphoma. Cancer chemotherapy report., 59(6), 1155-1156. | en_US |
| dc.identifier.uri | http://197.255.68.203/handle/123456789/3865 | |
| dc.language.iso | en | en_US |
| dc.publisher | Cancer chemotherapy reports | en_US |
| dc.title | Evaluation of CCNU (NSC 79037) used for the prevention of CNS involvement in burkitt's lymphoma | en_US |
| dc.type | Article | en_US |